Media-OutReach Newswire Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins
Media-OutReach Newswire Key risk trends for Directors and Officers in 2025: insolvencies, geopolitical tension and "AI washing": Allianz
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.